Summary
The authors isolated a specific cDNA clone (clone 14) for non-A, non-B hepatitis virus infection. In this study, we developed an enzyme-linked immunosorbent assay (ELISA) using a synthetic oligopeptide encoded by clone 14 and examined its usefulness for detecting hepatitis C virus (HCV) antibody in 181 patients with chronic NANB hepatitis, 88 with cirrhosis and 24 with hepatocellular carcinoma associated with NANB hepatitis virus. Anti-clone 14 antibody was detected in 75% of patients with chronic NANB hepatitis, 57% of cirrhotic patients and 58% hepatocellular carcinoma patients. Anticlone 14 and anti-C-100 antibody assayed using a commercial kit were found in serum from 199 (69%) and 205 (70%) of these 294 patients, respectively. Approximately 85% of the patients showed the presence of anticlone 14 and/or anti-C-100 antibodies. We compared the presence of these antibodies and the second generation anti-HCV antibody using ELISA and HCV RNA by the polymerase chain reaction assay, in the same blood samples from 49 patients with chronic liver disease who had anti-clone 14 and/or anti-C-100 antibody. HCV RNA was detected in 38 of 40 (95%) plasma samples containing anti-clone 14 antibody, the prevalence of which was similar to that for anti-C-100 antibody (41/42, 98%) and the second generation antiHCV antibody (46/47, 98%). Furthermore, 6 of 7 plasma samples containing anti-clone 14 antibody and lacking anti-C-100 antibody were positive for the second generation anti-HCV antibody and HCV RNA. These results indicate that anti-clone 14 antibody complements anti-C-100 antibody and that the ELISA of anti-clone 14 antibody is useful for the diagnosis of HCV infection.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Choo Q-L, Kou G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne Non-A, Non-B viral hepatitis genome. Science 1989;244:359–362.
Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1898;244:362–364.
Hopf U, Moller B, Kuther D, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatology 1990; 10:69–76.
Bruix J, Barrea JM, Calvet X, et al. Prevalence of antibodies to hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2: 1004–1006.
Colombo M, Kuo G, Choo Q-L, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006–1008.
Choo Q-L, Weiner AJ, Overby LR, et al. Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Brit Med Bull 1990;46:423–441.
Katayama T, Kikuchi S, Tanaka Y, et al. Blood screening for NonA, Non-B hepatitis by hepatitis C virus antibody assay. Transfusion 1990;30:374–376.
Arima T, Nagashima H, Murakami S, et al. Cloning of a cDNA associated with acute and chronic hepatitis C infection generated from patients serum RNA. Gastroenterol Jpn 1989;24:540–544.
Arima T, Takamizawa A, Mori C, et al. A lambda gtll-cDNA clone specific for chronic hepatitis C generated from pooled serum presumably infected by hepatitis C virus. Gastroenterol Jpn 1989; 24:545–548.
Arima T, Mori C, Takamizawa A, et al. A cDNA clone encoding a peptide highly specific for hepatitis C infection. Gastroenterol Jpn 1990;25:1110–111.
European patent application number: 88310922.5.
Okamoto H, Okada S, Sugiyama Y, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jap J Exp Med 1990;60:167–177.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction 1987;162:156–159.
Enomoto N, Takada A, Nakao T, et al. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990;170:1021–1025.
Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487–491.
Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5-noncoding region. Japan J Exp Med 1990;60:215–222.
Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990;335:l-3.
McFarlane IG, Smith HM, Johnson PJ, et al. Hepatitis C virus antibodies in chronic active hepatitis: pathogenic factor or falsepositive? Lancet 1990;335:754–757.
Bradley DW, Maynard JE. Etiology and natural history of posttransfusion and enterically-transmitted Non-A, Non-B hepatitis. Semin Liver Dis 1986;6:56–66.
Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 1990;1336:1469–1472.
Kato N, Ohkoshi S, Shimotohno K. Japanese isolates of the NonA, Non-B hepatitis viral genome show sequence variations from the original isolates in the U.S.A. Proc Japan Acad 1989;65:219–223.
Okamoto H, Munekata E, Tsuda F, et al. Enzyme linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. Jap J Exp Med 1990;60:223–233.
Mishiro S, Hoshi Y, Takeda K, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an, autoimmune process. Lancet 1990;336:1400–1403.
Mimms L, Vallari D, Ducharme L, et al. Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet 1990;336:1590–1591.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oketani, M., Kawabata, H., Imamura, S. et al. Development of a specific enzyme-linked immunosorbent assay for the hepatitis C virus antibody using clone 14. Gastroenterol Jpn 28, 56–63 (1993). https://doi.org/10.1007/BF02775004
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02775004